Overexpression of the anti-apoptotic caspase-2 short isoform in macrophage-derived foam cells of human atherosclerotic plaques

American Journal of Pathology

Volumn 162, Issue 3, 2003, Pages 731-736

  Martinet, Wim ^a   Knaapen, Michiel W M ^b   De Meyer, Guido R Y ^a   Herman, Arnold G ^a   Kockx, Mark M ^a,c  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b HistoGeneX NV   (Belgium)

^c MIDDELHEIM HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CAMPTOTHECIN; CASPASE 2; CASPASE 2L; CASPASE 2S; CASPASE 3; CYSTEINE PROTEINASE; ETOPOSIDE; ISOENZYME; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL CULTURE; CELL DEATH; CELL LYSATE; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; ENDARTERECTOMY; ENDOTHELIUM CELL; FOAM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE; MAMMARY ARTERY; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

EID: 0344643426     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63869-2     Document Type: Article

References (36)

1. Kockx MM: Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler Thromb Vasc Biol 1998, 18:1519-1522
2. McCarthy NJ, Bennett MR: The regulation of vascular smooth muscle cell apoptosis. Cardiovasc Res 2000, 45:747-755
3. Mallat Z, Tedgui A: Apoptosis in the vasculature: mechanisms and functional importance. Br J Pharmacol 2000, 130:947-962
4. Kockx MM, Herman AG: Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res 2000, 45:736-746
5. Martinet W, Kockx MM: Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation. Curr Opin Lipidol 2001, 12:535-541
6. Kockx MM, De Meyer GRY, Muhring J, Jacob W, Bult H, Herman AG: Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 1998, 97:2307-2315
7. Kockx MM, De Meyer GRY, Buyssens N, Knaapen MWM, Bult H, Herman AG: Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res 1998, 83:378-387
8. Mallat Z, Tedgui A: Current perspective on the role of apoptosis in atherothrombotic disease. Circ Res 2001, 88:998-1003
9. Nicholson DW: Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 1999, 6:1028-1042
10. Van de Craen M, Declercq W, Van den brande I, Fiers W, Vandenabeele P: The proteolytic procaspase activation network: an in vitro analysis. Cell Death Differ 1999, 6:1117-1124
11. Wang L, Miura M, Bergeron L, Zhu H, Yuan J: Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994, 78:739-750
12. Colussi PA, Harvey NL, Kumar S: Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor: a novel function for a caspase prodomain. J Biol Chem 1998, 273:24535-24542
13. Butt AJ, Harvey NL, Parasivam G, Kumar S: Dimerization and autoprocessing of the Nedd2 (caspase-2) precursor requires both the prodomain and the carboxyl-terminal regions. J Biol Chem 1998, 273:6763-6768
14. Duan H, Dixit VM: RAIDD is a new "death" adaptor molecule. Nature 1997, 385:86-89
15. Mancini M, Machamer CE, Roy S, Nicholson DW, Thornberry NA, Casciola-Rosen LA, Rosen A: Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J Cell Biol 2000, 149:603-612
16. Mallat Z, Ohan J, Lesèche G, Tedgui A: Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques. Circulation 1997, 96:424-428
17. Geng Y-J, Libby P: Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1β-converting enzyme. Am J Pathol 1995, 147:251-266
18. Nicholson DW: From bench to clinic with apoptosis-based therapeutic agents. Nature 2000, 407:810-816
19. Martinet W, Knaapen MWM, De Meyer GRY, Herman AG, Kockx MM: Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002, 106:927-932
20. Martinet W, Knaapen MWM, De Meyer GRY, Herman AG, Kockx MM: Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circ Res 2001, 88:733-739
21. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000, 20:1262-1275
22. Kockx MM, Muhring J, Knaapen MWM, De Meyer GRY: RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am J Pathol 1998, 152:885-888
23. Droin N, Dubrez L, Eymin B, Renvoizé C, Bréard J, Dimanche-Boitrel MT, Solary E: Up-regulation of casp genes in human tumor cells undergoing etoposide-induced apoptosis. Oncogene 1998, 16:2885-2894
24. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Brenner C, Larochette N, Prévost M-C, Alzari PM, Kroemer G: Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med 1999, 189:381-393
25. Zhivotovsky B, Samali A, Gahm A, Orrenius S: Caspases: their intracellular localization and translocation during apoptosis. Cell Death Differ 1999, 6:644-651
26. Droin N, Rébé C, Bichat F, Hammann A, Bertrand R, Solary E: Modulation of apoptosis by procaspase-2 short isoform: selective inhibition of chromatin condensation, apoptotic body formation, and phosphatidylserine externalization. Oncogene 2001, 20:260-269
27. Perlman H, Pagliari LJ, Georganas C, Mano T, Walsh K, Pope RM: FLICE-inhibitory protein expression during macrophage differentiation confers resistance to Fas-mediated apoptosis. J Exp Med 1999, 190:1679-1688
28. Wozniak AJ, Ross WE: DNA damage as a basis for 4′-demethylepipodophyllotoxin-9-(4, 6-O-ethylidene-β-D-glucopyranoside) (etoposide) cytotoxicity. Cancer Res 1983, 43:120-124
29. Roberston JD, Enoksson M, Suomela M, Zhivotovsky B, Orrenius S: Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 2002, 277:29803-29809
30. Lassus P, Opitz-Araya X, Lazebnik Y: Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 2002, 297:1352-1354
31. Ahmad M, Srinivasula SM, Wang L, Talanian RV, Litwack G, Fernandes-Alnemri T, Alnemri ES: CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res 1997, 57:615-619
32. Shearwin-Whyatt LM, Harvey NL, Kumar S: Subcellular localization and CARD-dependent oligomerization of the death adaptor RAIDD. Cell Death Differ 2000, 7:155-165
33. Pieper AA, Verma A, Zhang J, Snyder SH: Poly (ADP-ribose) polymerase, nitric oxide, and cell death. Trends Pharmacol Sci 1999, 20:171-181
34. Cromheeke KM, Kockx MM, De Meyer GRY, Bosmans JM, Bult H, Beelaerts WJF, Vrints CJ, Herman AG: Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques. Cardiovasc Res 1999, 43:744-754
35. Kunsch C, Medford RM: Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999, 85:753-766
36. Côté J, Dupuis S, Wu JY: Polypyrimidine track-binding protein binding downstream of caspase-2 alternative exon 9 represses its inclusion. J Biol Chem 2001, 276:8535-8543